Economic burden of heart failure: Investigating outpatient and inpatient costs in Abeokuta, Southwest Nigeria

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Ogah, Okechukwu S ^a,b   Stewart, Simon ^b,f   Onwujekwe, Obinna E ^d   Falase, Ayodele O ^a   Adebayo, Saheed O ^e   Olunuga, Taiwo ^e   Sliwa, Karen ^b,c  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNIVERSITY OF NIGERIA   (Nigeria)

^e FEDERAL MEDICAL CENTER   (Nigeria)

^f NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; AMLODIPINE; AMOXICILLIN PLUS CLAVULANIC ACID; ATORVASTATIN; CARVEDILOL; DIGOXIN; FUROSEMIDE; HYDRALAZINE; ISOSORBIDE DINITRATE; LISINOPRIL; LOW MOLECULAR WEIGHT HEPARIN; PREDNISOLONE; SPIRONOLACTONE; WARFARIN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DATA EXTRACTION; DISEASE REGISTRY; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HEART FAILURE; HOSPITAL CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; NIGERIA; OUTPATIENT CARE; PROSPECTIVE STUDY; COST OF ILLNESS; ECONOMICS; HOSPITAL PATIENT; HOSPITALIZATION; MIDDLE AGED; OUTPATIENT; PATIENT TRANSPORT; REGISTER; STATISTICS AND NUMERICAL DATA; TERTIARY CARE CENTER;

ADULT; AGED; COST OF ILLNESS; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HEALTH EXPENDITURES; HEART FAILURE; HOSPITALIZATION; HUMANS; INPATIENTS; MALE; MIDDLE AGED; NIGERIA; OUTPATIENTS; PROSPECTIVE STUDIES; REGISTRIES; TERTIARY CARE CENTERS; TRANSPORTATION OF PATIENTS;

EID: 84912571943     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113032     Document Type: Article

References (35)

1. Cook C, Cole G, Asaria P, Jabbour R, Francis DP (2014) The annual global economic burden of heart failure. Int J Cardiol 171: 368-376.
2. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, et al. (2003) Burden of systolic and diastolic ventricular dysfunction in the community: Appreciating the scope of the heart failure epidemic. JAMA 289: 194-202.
3. Mosterd A, Hoes AW, de Bruyne MC, Deckers JW, Linker DT, et al. (1999) Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J 20: 447- 455.
4. Wijeysundera HC, Machado M, Wang X, Van Der Velde G, Sikich N, et al. (2010) Cost-effectiveness of specialized multidisciplinary heart failure clinics in Ontario, Canada. Value Health 13: 915-921.
5. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, et al. (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33: 1787-1847.
6. Nagamine M, Jiang HJ, Merrill CT (2006) Trends in Elderly Hospitalizations, 1997-2004: Statistical Brief #14. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD).
7. Hines A, Stranges E, Andrews RM (2006) Trends in Hospital Risk-Adjusted Mortality for Select Diagnoses by Patient Subgroups, 2000-2007: Statistical Brief #98. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville (MD).
8. MacIntyre K, Capewell S, Stewart S, Chalmers JW, Boyd J, et al. (2000) Evidence of improving prognosis in heart failure: Trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation 102: 1126-1131.
9. Schaufelberger M, Swedberg K, Koster M, Rosen M, Rosengren A (2004) Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000. Eur Heart J 25: 300-307.
10. Stewart S, Jenkins A, Buchan S, McGuire A, Capewell S, et al. (2002) The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail 4: 361-371.
11. Ryden-Bergsten T, Andersson F (1999) The health care costs of heart failure in Sweden. J Intern Med 246: 275-284.
12. Araujo DV, Tavares LR, Verissimo R, Ferraz MB, Mesquita ET (2005) [Cost of heart failure in the Unified Health System]. Arq Bras Cardiol 84: 422-427.
13. Stewart S (2005) Financial aspects of heart failure programs of care. Eur J Heart Fail 7: 423-428.
14. Stewart S, Wilkinson D, Hansen C, Vaghela V, Mvungi R, et al. (2008) Predominance of heart failure in the Heart of Soweto Study cohort: emerging challenges for urban African communities. Circulation 118: 2360-2367.
15. Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, et al. (2008) Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): A cohort study. Lancet 371: 915-922.
16. Ojji D, Stewart S, Ajayi S, Manmak M, Sliwa K (2013) A predominance of hypertensive heart failure in the Abuja Heart Study cohort of urban Nigerians: A prospective clinical registry of 1515 de novo cases. Eur J Heart Fail 15: 835-842.
17. Ojji DB, Alfa J, Ajayi SO, Mamven MH, Falase AO (2009) Pattern of heart failure in Abuja, Nigeria: An echocardiographic study. Cardiovasc J Afr 20: 349-352.
18. Laabes EP, Thacher TD, Okeahialam BN (2008) Risk factors for heart failure in adult Nigerians. Acta Cardiol 63: 437-443.
19. Ogah OS, Stewart S, Falase AO, Akinyemi JO, Adegbite GD, et al. (2014) Contemporary Profile of Acute Heart Failure in Southern Nigeria: Data From the Abeokuta Heart Failure Clinical Registry. JACC Heart Fail 2: 250-259.
20. Oyoo GO, Ogola EN (1999) Clinical and socio demographic aspects of congestive heart failure patients at Kenyatta National Hospital, Nairobi. East Afr Med J 76: 23-27.
21. Rits IA (1964) Declaration of Helsinki. Recommendations Guidings Doctors in Clinical Research. World Med J 11: 281.
22. Ogun State. Available: http://en.wikipedia.org/wiki/Ogun-State. Accessed 2014 August 10.
23. Abeokuta. Available: http://en.wikipedia.org/wiki/Abeokuta. Accessed 2014 August 10.
24. Soyibo A, Olaniyan O, Lawanson OA National health accounts: Structure, trends and sustainability of health expenditure in Nigeria. African Journal of Economic Policy 14.
25. Lawanson AO, Olaniyan O, Soyibo A (2012) National Health Accounts estimation: lessons from the Nigerian experience. Afr J Med Med Sci 41: 357-364.
26. Atlas of African Health Statistics. Available: http://www.aho.afro.who.int/en/publication/63/atlas- Africanhealth-statistics-2012-health-situation- Analysis- African-region. Accessed 2014 August 10.
27. International Statistical Classification of Diseases and Related Health Problems 10th Revision. Available: http://www.who.int/classifications/icd/en/. Accessed 2014 August 10.
28. Falase B, Sanusi M, Majekodunmi A, Ajose I, Idowu A, et al. (2013) The cost of open heart surgery in Nigeria. Pan Afr Med J 14: 61.
29. Johnson A, Falase B, Ajose I, Onabowale Y (2014) A Cross-sectional study of stand- Alone Percutaneous Coronary Intervention in a Nigerian Cardiac Catheterization Laboratory. BMC Cardiovasc Disord 14: 8.
30. Czech M, Opolski G, Zdrojewski T, Dubiel JS, Wizner B, et al. (2013) The costs of heart failure in Poland from the public payer's perspective. Polish programme assessing diagnostic procedures, treatment and costs in patients with heart failure in randomly selected outpatient clinics and hospitals at different levels of care: POLKARD. Kardiol Pol 71: 224-232.
31. Writing Group M, Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, et al. (2010) Heart disease and stroke statistics-2010 update: A report from the American Heart Association. Circulation 121: e46- e215.
32. Fagnani F, Buteau L, Virion JM, Briancon S, Zannad F (2001) [Management, cost and mortality of a cohort of patients with advanced heart failure (the EPICAL study)]. Therapie 56: 5-10.
33. Whellan DJ, Greiner MA, Schulman KA, Curtis LH (2010) Costs of inpatient care among Medicare beneficiaries with heart failure, 2001 to 2004. Circ Cardiovasc Qual Outcomes 3: 33-40.
34. McMurray J, Davie A (1996) The pharmacoeconomics of ACE inhibitors in chronic heart failure. Pharmacoeconomics 9: 188-197.
35. McMurray JJ, Hart W, Rhodes G (1993) An evaluation of the cost of heart failure to the National Health Service in the UK. Br J Med Econ 6: 91-98.